TOT BIOPHARM International Gestion
Gestion contrôle des critères 3/4
We currently do not have sufficient information about the CEO.
Informations clés
Jun Liu
Directeur général
CN¥7.5m
Rémunération totale
| Pourcentage du salaire du PDG | 49.5% |
| Durée du mandat du directeur général | 5.7yrs |
| Propriété du PDG | n/a |
| Durée moyenne d'occupation des postes de direction | 4.2yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 5.7yrs |
Mises à jour récentes de la gestion
Recent updates
We Think Some Shareholders May Hesitate To Increase TOT BIOPHARM International Company Limited's (HKG:1875) CEO Compensation
Jun 07
The Market Lifts TOT BIOPHARM International Company Limited (HKG:1875) Shares 29% But It Can Do More
May 21Is TOT BIOPHARM International (HKG:1875) Using Debt In A Risky Way?
Mar 18There's No Escaping TOT BIOPHARM International Company Limited's (HKG:1875) Muted Revenues
Dec 28Does TOT BIOPHARM International (HKG:1875) Have A Healthy Balance Sheet?
Nov 23We Think TOT BIOPHARM International (HKG:1875) Has A Fair Chunk Of Debt
May 18Here's Why We're Watching TOT BIOPHARM International's (HKG:1875) Cash Burn Situation
Jul 27An Intrinsic Calculation For TOT BIOPHARM International Company Limited (HKG:1875) Suggests It's 41% Undervalued
Mar 26Here's Why We're Watching TOT BIOPHARM International's (HKG:1875) Cash Burn Situation
Feb 03Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥9m |
| Mar 31 2024 | n/a | n/a | -CN¥14m |
| Dec 31 2023 | CN¥8m | CN¥4m | -CN¥38m |
| Sep 30 2023 | n/a | n/a | -CN¥44m |
| Jun 30 2023 | n/a | n/a | -CN¥49m |
| Mar 31 2023 | n/a | n/a | -CN¥50m |
| Dec 31 2022 | CN¥5m | CN¥3m | -CN¥50m |
| Sep 30 2022 | n/a | n/a | -CN¥106m |
| Jun 30 2022 | n/a | n/a | -CN¥162m |
| Mar 31 2022 | n/a | n/a | -CN¥212m |
| Dec 31 2021 | CN¥3m | CN¥2m | -CN¥261m |
Rémunération vs marché: Jun's total compensation ($USD1.06M) is above average for companies of similar size in the Hong Kong market ($USD359.95K).
Rémunération et revenus: Jun's compensation has been consistent with company performance over the past year.
PDG
Jun Liu (56 yo)
5.7yrs
Titularisation
CN¥7,528,000
Compensation
Dr. Jun Liu serves as Chief Executive Officer at TOT BIOPHARM International Company Limited since October 15, 2020 and serves as its Executive Director since October 26, 2018. Dr. Liu serves as Chief Scien...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO, Chief Scientific Officer & Executive Director | 5.7yrs | CN¥7.53m | pas de données | |
| Executive Finance Director | 2.8yrs | pas de données | pas de données | |
| Joint Company Secretary | 5.6yrs | pas de données | pas de données | |
| Joint Company Secretary | 2.8yrs | pas de données | pas de données |
4.2yrs
Durée moyenne de l'emploi
43yo
Âge moyen
Gestion expérimentée: 1875's management team is considered experienced (4.2 years average tenure).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO, Chief Scientific Officer & Executive Director | 6.1yrs | CN¥7.53m | pas de données | |
| Chairman of the Board | 8.8yrs | pas de données | pas de données | |
| Independent Non-Executive Director | 5.7yrs | CN¥282.00k | pas de données | |
| Non-Executive Vice Chairman of the Board | 8.8yrs | CN¥600.00k | 0.71% HK$ 9.8m | |
| Independent Non-Executive Director | 5.7yrs | CN¥282.00k | pas de données | |
| Non-Executive Director | 1.3yrs | pas de données | pas de données | |
| Independent Non-Executive Director | 2.7yrs | CN¥282.00k | pas de données |
5.7yrs
Durée moyenne de l'emploi
56yo
Âge moyen
Conseil d'administration expérimenté: 1875's board of directors are considered experienced (5.7 years average tenure).